Nemat O. Borhani

TL;DR: The temporal trends in antihypertensive drug therapy coincided in time with and may have reflected in part the influence of the major clinical trials on the patterns of clinical practice.

TL;DR: Little evidence is provided of an important role of combinations of cation supplements in the treatment of mild or borderline hypertension and the mean differences in systolic and diastolic blood pressures between the treatment and placebo groups were not significant.

TL;DR: The relationship is weak and a causal interpretation of these immediate results cannot be argued persuasively, but examinations of specific cancer sites and factors related to serum cholesterol are suggested as important lines of research toward clarification of the complex relationships observed.

TL;DR: In a randomized, multicenter investigation that included double-blind, placebo-controlled testing of calcium and magnesium supplements among 698 healthy adults (10.5% blacks and 31% women) aged 30 to 54 years with high-normal diastolic blood pressure (DBP) (80 to 89 mm Hg) as mentioned in this paper, neither calcium nor magnesium produced significant changes in blood pressure at 3 and 6 months.

TL;DR: Echocardiographic and electrocardiographic models both demonstrated similar and about equally strong associations with overt and subclinical disease and with risk factors for left ventricular hypertrophy, demonstrating the potential utility of electrocardIographic models forleft ventricular mass estimation.